-
-
No events on calendar for this bill.
-
Ref To Com On Rules, Calendar, and Operations of the HouseHouse2021-05-05Passed 1st ReadingHouse2021-05-05FiledHouse2021-05-04
-
FiledNo fiscal notes available.Edition 1No fiscal notes available.
-
CONTROLLED SUBSTANCES
CRIMES
DISEASES & HEALTH DISORDERS
HEALTH SERVICES
OCCUPATIONS
PHARMACEUTICALS
PHYSICIANS
PUBLIC
PUBLIC HEALTH
RESEARCH
LIABILITY
MARIJUANA
-
90 (Chapters); 90-113.100
90-113.101
90-113.102
90-113.105
90-113.105.5
90-94.1 (Sections)
-
No counties specifically cited.
-
-
-
H858: Permit Cannabis Medical Research Studies. Latest Version
2021-2022
AN ACT permitting cannabis medical research studies.
The General Assembly of North Carolina enacts:
SECTION 1. G.S. 90‑94.1 reads as rewritten:
§ 90‑94.1. Exemption for use or possession of hemp extract.cannabis.
(a) As used in this section, hemp extract means an extract from a cannabis plant, or a mixture or preparation containing cannabis plant material, that has all of the following characteristics:
(1) Is composed of less than nine‑tenths of one percent (0.9%) tetrahydrocannabinol by weight.
(2) Is composed of at least five percent (5%) cannabidiol by weight.
(3) Contains no other psychoactive substance.
(a1) As used in this section, cannabis has the same meaning as marijuana in G.S. 90‑87.
(b) Notwithstanding any other provision of this Chapter, an individual may possess or use hemp extract, cannabis and is not subject to the penalties described in this Chapter, if the individual satisfies all of the following criteria:
(1) Possesses or uses the hemp extract only cannabis to treat intractable epilepsy, as defined in G.S. 90‑113.101.one or more medical conditions if the quantity of usable cannabis possessed does not exceed an adequate supply, as determined by the patient's physician.
(2) Possesses, in close proximity to the hemp extract, a certificate of analysis that indicates the hemp extract's ingredients, including its percentages of tetrahydrocannabinol and cannabidiol by weight.cannabis a written certification, as defined in G.S. 90‑113.101.
(3) Is a caregiver, as defined in G.S. 90‑113.101.
(c) Notwithstanding any other provision of this Chapter, an individual who possesses hemp extract cannabis lawfully under this section may administer hemp extract cannabis to another person under the individual's care and is not subject to the penalties described in this Chapter for administering the hemp extract cannabis to the person if the individual is the person's caregiver, as defined in G.S. 90‑113.101.
(d) Any individual who possesses or uses hemp extract, cannabis, as defined under this section, shall dispose of all residual oil from the extract any unused portions at a secure collection box managed by a law enforcement agency. No criminal penalty shall attach for any violation of this subsection.
SECTION 2. Article 5G of Chapter 90 of the General Statutes reads as rewritten:
Article 5G.
Epilepsy Cannabis Alternative Treatment Act.
§ 90‑113.100. (Repealed effective July 1, 2021) Short title.
(a) This act may be cited as the North Carolina Epilepsy Cannabis Alternative Treatment Act.
(b) The purpose of this act is to permit the use of hemp extract cannabis as an alternative treatment for intractable epilepsy.medical conditions.
(c) The General Assembly finds that there are children makes the following findings:
(1) There are individuals in this State suffering from intractable epilepsy medical conditions for which currently available treatment options have been ineffective. Hemp extract ineffective.
(2) The available treatment options for many medical conditions have side effects with greater risks than cannabis or the treatment options can be improved when combined with cannabis.
(3) Cannabis shows promise in treating children with intractable epilepsy.individuals for a variety of medical conditions.
§ 90‑113.101. (Repealed effective July 1, 2021) Definitions.
The following definitions apply in this Article:
(1) Cannabis. – Has the same meaning as marijuana in G.S. 90‑87 and refers to quantities of 1.5 ounces or less.
(1a) Caregiver. – An individual that is at least 18 years of age and a resident of North Carolina who is a parent, legal guardian, or custodian of a patient and is registered with the Department of Health and Human and Services under G.S. 90‑113.102 who possesses a written statement dated and signed by a neurologist physician that states all of the following:
a. The patient has been examined and is under the care of the neurologist.physician.
b. The patient suffers from intractable epilepsy.a medical condition.
c. The patient may benefit from treatment with hemp extract.cannabis.
(2) Repealed by Session Laws 2015‑154, s. 3, effective July 16, 2015.
(3) Database. – The Intractable Epilepsy Cannabis Alternative Treatment database, established by the Department of Health and Human Services pursuant to this Article.
(4) Department. – The Department of Health and Human Services.
(5) Hemp Extract. – An extract from a cannabis plant, as defined in G.S. 90‑94.1(a).
(6) Intractable Epilepsy. – A seizure disorder that, as determined by a neurologist, does not respond to three or more treatment options overseen by the neurologist.
(7) Neurologist. – An individual who is licensed under Article 1 of Chapter 90 of the General Statutes, who is board certified in neurology, and is affiliated with the neurology department at one or more hospitals licensed in this State.
(8) Patient. – A person who has been diagnosed by a neurologist with intractable epilepsy.physician with one or more medical conditions.
(9) Repealed by Session Laws 2015‑154, s. 3, effective July 16, 2015.
(10) Physician. – A person licensed under Article 1 of Chapter 90 of the General Statutes who is in good standing to practice medicine in this State.
(11) Written certification. – A statement in a patient's medical records or a statement signed by a physician with whom the patient has a bona fide physician patient relationship indicating that, in the physician's professional opinion, the patient has a medical condition and the potential health benefits of the medical use of cannabis would likely outweigh the health risks for the patient.
§ 90‑113.102. (Repealed effective July 1, 2021) Intractable Epilepsy Cannabis Alternative Treatment database; departmental duties.
(a) The Department shall create a secure and electronic Intractable Epilepsy Cannabis Alternative Treatment database registry for the registration of neurologists, physicians, caregivers, and patients as provided by this Article. All caregivers shall be required to register with the Department. Law enforcement agencies are authorized to contact the Department to confirm a caregiver's registration. The database shall consist of the following information to be provided by the caregivers at the time of registration:
(1) The name and address of the caregiver.
(2) The name and address of the caregiver's patient.
(3) Repealed by Session Laws 2015‑154, s. 4, effective July 16, 2015.
(4) The name, address, and hospital affiliation of the neurologist physician recommending hemp extract cannabis as an alternative treatment for intractable epilepsy for the patient.a patient's medical condition.
(b) Repealed by Session Laws 2015‑154, s. 4, effective July 16, 2015.
(c) If at any time following registration, the name, address, or hospital affiliation of the patient's neurologist physician changes, the caregiver shall notify the Department and provide the Department with the name, address, and hospital affiliation of the patient's new neurologist'sname, address, and hospital affiliation.physician.
…
§ 90‑113.105. (Repealed effective July 1, 2021) Immunity for neurologists; physicians; confidentiality.
(a) On a case‑by‑case basis, neurologists physicians may approve of dispensation to a registered caregiver, as approved by this Article, hemp extract cannabis acquired from another jurisdiction.
(a1) Neurologists Physicians who approve of dispensation of hemp extract cannabis to a registered caregiver, as approved by this Article, shall inform the registered caregiver of the requirement that disposal must be done at a secure collection box pursuant to G.S. 90‑94.1.
(b) A neurologist physician shall not be subject to arrest or prosecution, penalized or disciplined in any manner, or denied any right or privilege for approving or recommending the use of hemp extract cannabis or providing a written statement certification for the use of hemp extract cannabis pursuant to this Article.
(c) Repealed by Session Laws 2015‑154, s. 7, effective July 16, 2015.
(d) The identities of the caregivers, patients, and neurologists physicians reported to the Department pursuant to this Article are confidential and are not matters of public record. However, this information may be provided to law enforcement agencies pursuant to G.S. 9‑113.102.
§ 90‑113.105.5. North Carolina Cannabis Research Program.
(a) It is the intent of the General Assembly that any physician who issues a written certification to a patient be permitted to participate in objective scientific research with persons registered under G.S. 90‑113.102 regarding the administration of cannabis as part of medical treatment.
(b) The scientific research conducted under this Article may involve the development of quality control, purity, and labeling standards for cannabis; sound advice and recommendations on the best practices for the safe and efficient medical use of cannabis; and analysis of genetic and healing properties of the many varied strains of cannabis to determine which strains may be best suited for a particular medical condition or treatment.
(c) A physician or person registered to conduct research under G.S. 90‑113.102 shall not be subject to arrest or prosecution, or penalized in any manner, or denied any right or privilege for recommending the medical use of cannabis or providing written certification for the medical use of cannabis pursuant to this section.
….
SECTION 3. The provisions of this act are severable. If any provision of this act is held invalid by a court of competent jurisdiction, the invalidity shall not affect other provisions of this act which can be given effect without the invalid provision.
SECTION 4. This act becomes effective July 1, 2021, and applies to offenses committed on or after that date.